Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPFZ.L Regulatory News (PFZ)

  • There is currently no data for PFZ

Rule 38.5 - Pfizer INC

3 Nov 2015 11:56

RNS Number : 3758E
Morgan Stanley Capital Services LLC
03 November 2015
Ā 

Ā 

Ā FORM 38.5(a)

Ā 

IRISHĀ TAKEOVERĀ PANEL

Ā 

DISCLOSUREĀ UNDERĀ RULEĀ 38.5(a)Ā OFĀ THEĀ IRISHĀ TAKEOVERĀ PANELĀ ACT,Ā 1997, TAKEOVER Ā RULES,Ā 2013

Ā 

DEALINGS BY CONNECTEDĀ EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARYĀ STATUS AND DEALING IN A CLIENT-SERVING CAPACITY

Ā 

Ā 

1. KEYĀ INFORMATION

Ā Name of exempt market-maker

Morgan Stanley Capital Services LLC

Ā Company dealt in

PFIZER INC

Ā Class of relevant security to which the dealings being disclosed relate (Note 1)

US$0.05 COMMON STOCK

Ā Date of dealing

02 NOVEMBER 2015

Ā 

Ā 

2. DEALINGSĀ (NoteĀ 2)

Ā 

(a) PurchasesĀ andĀ sales

Ā Total number of relevant secuities accquired

Ā Highest price paid (Note 3)

Ā Lowest price paid (Note 3)

Ā Ā 568,781

Ā 35.2500 USD

Ā 34.1500 USD

Ā 

Ā Total number of relevant secuities disposed

Ā Highest price paid (Note 3)

Ā Lowest price paid (Note 3)

Ā Ā 245,727

Ā 35.2400 USD

Ā 34.1600 USD

Ā 

Ā 

(b) DerivativesĀ transactionsĀ (otherĀ thanĀ optionsĀ transactions)

Ā 

Ā Product name, e.g. CFD

Ā Nature of transaction

(Note 4)

Ā Number of relevant securities

(Note 5)

Ā Price per unit

Ā CFD

Ā LONG

Ā 599

Ā 34.1700 USD

Ā CFD

Ā LONG

Ā 392

Ā 34.1800 USD

Ā CFD

Ā LONG

Ā 200

Ā 34.2300 USD

Ā CFD

Ā LONG

Ā 400

Ā 34.2400 USD

Ā CFD

Ā LONG

Ā 440

Ā 34.6000 USD

Ā CFD

Ā LONG

Ā 160

Ā 34.7900 USD

Ā CFD

Ā LONG

Ā 359

Ā 34.8002 USD

Ā CFD

Ā LONG

Ā 919

Ā 34.8002 USD

Ā CFD

Ā LONG

Ā 6,090

Ā 34.8456 USD

Ā CFD

Ā LONG

Ā 87

Ā 34.8493 USD

Ā CFD

Ā LONG

Ā 33

Ā 34.8493 USD

Ā CFD

Ā LONG

Ā 4,900

Ā 34.8530 USD

Ā CFD

Ā LONG

Ā 23,708

Ā 34.8974 USD

Ā CFD

Ā LONG

Ā 5,800

Ā 34.9015 USD

Ā CFD

Ā LONG

Ā 4,600

Ā 34.9356 USD

Ā CFD

Ā LONG

Ā 10,700

Ā 34.9460 USD

Ā CFD

Ā LONG

Ā 1

Ā 34.9500 USD

Ā CFD

Ā LONG

Ā 888

Ā 34.9578 USD

Ā CFD

Ā LONG

Ā 33

Ā 34.9578 USD

Ā CFD

Ā LONG

Ā 20

Ā 34.9578 USD

Ā CFD

Ā LONG

Ā 280

Ā 34.9578 USD

Ā CFD

Ā LONG

Ā 3,481

Ā 34.9578 USD

Ā CFD

Ā LONG

Ā 9,334

Ā 34.9676 USD

Ā CFD

Ā LONG

Ā 31,614

Ā 34.9793 USD

Ā CFD

Ā LONG

Ā 700

Ā 34.9928 USD

Ā CFD

Ā LONG

Ā 10,701

Ā 34.9947 USD

Ā CFD

Ā LONG

Ā 66

Ā 35.0000 USD

Ā CFD

Ā LONG

Ā 23,450

Ā 35.0051 USD

Ā CFD

Ā LONG

Ā 16

Ā 35.0100 USD

Ā CFD

Ā LONG

Ā 6

Ā 35.0100 USD

Ā CFD

Ā LONG

Ā 8,869

Ā 35.0560 USD

Ā CFD

Ā LONG

Ā 2

Ā 35.0572 USD

Ā CFD

Ā LONG

Ā 2

Ā 35.0572 USD

Ā CFD

Ā LONG

Ā 80

Ā 35.0572 USD

Ā CFD

Ā LONG

Ā 334

Ā 35.0572 USD

Ā CFD

Ā LONG

Ā 25

Ā 35.0572 USD

Ā CFD

Ā LONG

Ā 4,500

Ā 35.0655 USD

Ā CFD

Ā LONG

Ā 3,284

Ā 35.0657 USD

Ā CFD

Ā LONG

Ā 16

Ā 35.0657 USD

Ā CFD

Ā LONG

Ā 45,400

Ā 35.0729 USD

Ā CFD

Ā LONG

Ā 2,100

Ā 35.1200 USD

Ā CFD

Ā LONG

Ā 320

Ā 35.1800 USD

Ā CFD

Ā SHORT

Ā 1,000

Ā 34.2116 USD

Ā CFD

Ā SHORT

Ā 2,600

Ā 34.5726 USD

Ā CFD

Ā SHORT

Ā 8,316

Ā 34.5949 USD

Ā CFD

Ā SHORT

Ā 42,872

Ā 34.8827 USD

Ā CFD

Ā SHORT

Ā 2,700

Ā 34.9159 USD

Ā CFD

Ā SHORT

Ā 1,400

Ā 34.9200 USD

Ā CFD

Ā SHORT

Ā 111,999

Ā 34.9289 USD

Ā CFD

Ā SHORT

Ā 168

Ā 34.9652 USD

Ā CFD

Ā SHORT

Ā 2,013

Ā 34.9715 USD

Ā CFD

Ā SHORT

Ā 223

Ā 34.9847 USD

Ā CFD

Ā SHORT

Ā 643

Ā 34.9886 USD

Ā CFD

Ā SHORT

Ā 2,820

Ā 35.0118 USD

Ā CFD

Ā SHORT

Ā 131,749

Ā 35.0263 USD

Ā CFD

Ā SHORT

Ā 2,507

Ā 35.0314 USD

Ā CFD

Ā SHORT

Ā 26,600

Ā 35.0395 USD

Ā CFD

Ā SHORT

Ā 2,600

Ā 35.0600 USD

Ā CFD

Ā SHORT

Ā 22,879

Ā 35.0600 USD

Ā CFD

Ā SHORT

Ā 189

Ā 35.0600 USD

Ā CFD

Ā SHORT

Ā 15,804

Ā 35.0600 USD

Ā CFD

Ā SHORT

Ā 70,259

Ā 35.0696 USD

Ā CFD

Ā SHORT

Ā 26,600

Ā 35.0749 USD

Ā CFD

Ā SHORT

Ā 1,542

Ā 35.0828 USD

Ā 

Ā 

(c) OptionsĀ transactionsĀ inĀ respectĀ ofĀ existingĀ relevantĀ securities

Ā 

i) Writing,Ā selling,Ā purchasingĀ orĀ varying

Ā 

Ā Product name, eg call option

Ā Writing, selling, purchasing, varying etc

Ā Number of securities to which the option relates (Note 5)

Ā Exercise Price

Ā Type, e.g American, European etc

Ā Expiry Date

Ā Option money paid/received per unit (Note 3)

Ā N/A

Ā N/A

Ā N/A

Ā N/A

Ā N/A

Ā N/A

Ā N/A

Ā 

(ii) Exercising

Ā 

Ā Product name, eg call option

Ā Number of securities

Ā Exercise price per unit (Note 3)

Ā N/A

Ā N/A

Ā N/A

Ā 

Ā 

3. OTHER INFORMATION

Ā 

Agreements, arrangements or understandings relating to options or derivatives

Ā 

Full Details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā Date of disclosure

Ā 03 NOVEMBER 2015

Ā Contact Name

Craig Horsley

Ā Telephone Number

+44(141) 245 7736

Ā Name of offeree/offeror with which connected

ALLERGAN PLC

Nature of connection (Note 6)

Advisory

Ā 

This information is provided by RNS
The company news service from the London Stock Exchange
Ā 
END
Ā 
Ā 
ISEBJBBTMBAMBIA
Date   Source Headline
1st Mar 20178:51 amRNSPress Release
27th Feb 201710:45 amRNSPress Release
24th Feb 20172:19 pmRNSPress Release
22nd Feb 20177:00 amRNSCancellation of UK Listing
31st Jan 20172:56 pmRNSFourth Quarter and Full-Year 2016 Results
24th Nov 20153:20 pmRNSForm 8.3 - Pfizer Inc
24th Nov 20153:19 pmRNSForm 8.3 - Pfizer, Inc.
24th Nov 201512:14 pmRNSForm 38.5(b) - Pfizer Inc
24th Nov 201511:49 amRNSForm 8.1a - Pfizer Inc
24th Nov 201511:46 amRNSForm 38.5(a) - Pfizer Inc
24th Nov 201510:41 amRNSRule 38.5 - Pfizer INC
24th Nov 20157:00 amRNSForm 38.5(b) - Pfizer Inc
23rd Nov 20156:11 pmRNSForm 38.5(a) - Pfizer Inc
23rd Nov 20155:58 pmRNSForm 8.1a - Pfizer Inc
23rd Nov 20153:40 pmRNSForm 8.3 - PFIZER INC
23rd Nov 20153:34 pmRNSForm 8.3 - Pfizer Inc Amendment
23rd Nov 20153:31 pmRNSForm 8.3 - Pfizer Inc
23rd Nov 20153:31 pmRNSForm 8.3 - Pfizer Inc
23rd Nov 20153:28 pmRNSForm 8.3 - ALLERGAN PLC
23rd Nov 20153:21 pmRNSForm 8.3 - Pfizer, Inc.
23rd Nov 20152:56 pmRNSForm 8.3 - Pfizer Inc
23rd Nov 20152:39 pmRNSForm 8.3 - Pfizer Inc
23rd Nov 20152:29 pmRNSForm 8.3 - Allergan Plc
23rd Nov 201512:16 pmRNSForm 8.1 - [Pfizer Inc.]
23rd Nov 201512:04 pmRNSForm 38.5a
23rd Nov 201511:57 amRNSForm 38.5b
23rd Nov 201511:55 amRNSForm 38.5b
23rd Nov 201511:55 amRNSForm 8.3 - Pfizer Inc.
23rd Nov 201510:58 amRNSRule 38.5 - Pfizer INC
23rd Nov 201510:58 amRNSRule 38.5 - Pfizer INC
20th Nov 20153:43 pmRNSForm 8.3 - Pfizer Inc.
20th Nov 20153:34 pmRNSForm 8.3 - Pfizer Inc
20th Nov 20153:25 pmRNSForm 8.3 - Allergan plc
20th Nov 20153:21 pmRNSForm 8.3 - PFIZER INC
20th Nov 20153:17 pmRNSForm 8.3 - ALLERGAN PLC
20th Nov 20153:14 pmRNSForm 8.3 - Pfizer Inc
20th Nov 20153:11 pmRNSForm 8.3 - [PFIZER INC]
20th Nov 20153:07 pmRNSForm 8.3 - Pfizer Inc
20th Nov 20152:58 pmRNSForm 8.3 - Allergan plc
20th Nov 20152:57 pmRNSRule 38.5 - Replacement Pfizer INC
20th Nov 20152:52 pmRNSForm 8.3 - Allergan Plc
20th Nov 20152:44 pmRNSForm 8.3 - Pfizer, Inc.
20th Nov 201512:14 pmRNSForm 8.1 - [Pfizer Inc]
20th Nov 201511:57 amRNSForm 38.5b
20th Nov 201511:55 amRNSForm 8.3 - Pfizer Inc.
20th Nov 201511:53 amRNSForm 38.5b
20th Nov 201511:53 amRNSForm 38.5(b) - Pfizer Inc
20th Nov 201511:52 amRNSForm 38.5a
20th Nov 201511:18 amRNSForm 38.5(a) - Pfizer Inc
20th Nov 201510:37 amRNSRule 38.5 - Pfizer INC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.